期刊名称：HEALTH SECURITY ISSN： 2326-5094 出版频率： Bi-monthly 出版社： MARY ANN LIEBERT, INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801   出版社网址： http://www.liebertpub.com/Default.aspx 期刊网址： http://www.liebertpub.com/hs/ 主题范畴： PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 变更情况： Newly Added by 2015 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal ISSN: 2326-5094 • Online ISSN: 2326-5108 Health Security (formerly Biosecurity and Bioterrorism) is a peer-reviewed journal providing research and essential guidance for the protection of people’s health before and after epidemics or disasters and for ensuring that communities are resilient to major challenges. The Journal explores the issues posed by disease outbreaks and epidemics; natural disasters; biological, chemical, and nuclear accidents or deliberate threats; foodborne outbreaks; and other health emergencies. It offers important insight into how to develop the systems needed to meet these challenges. Taking an interdisciplinary approach, Health Security covers research, innovations, methods, challenges, and ethical and legal dilemmas facing scientific, military, and health organizations. The Journal is a key resource for practitioners in these fields, policymakers, scientific experts, and government officials. Health Security coverage includes: Scientific, medical, and policy advancements that might help prevent or respond to epidemics Future directions and innovations in public health that improve response to major health events Guidance for healthcare organizations planning to cope with mass casualty crises Initiatives or concepts intended to reduce agricultural vulnerabilities Military and intelligence roles and contributions to biodefense strategy and response Communication methods and challenges for decision makers, the media, and the public Ethical and legal dilemmas posed by major health events Health Security is under the editorial leadership of Editor-in-Chief Thomas V. Inglesby, MD, Director, UPMC Center for Health Security; Editor Emeritus D. A. Henderson, MD, MPH, Distinguished Scholar, UPMC Center for Health Security; and other leading investigators. View the entire editorial board. Audience: Emergency managers, homeland security policy experts, public health preparedness specialists, food and drug safety researchers and specialists, and policymakers, among others Indexed/Abstracted in: MEDLINE; PubMed; PubMed Central; Current Contents®/Social & Behavioral Sciences; Social Sciences Citation Index®; Social SciSearch®; Journal Citation Reports/Social Sciences Edition; EMBASE/Excerpta Medica; EMBiology; Scopus; ProQuest; CAB Abstracts; Global Health Instructions to Authors Information for Contributors   Health Security (formerly Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science) is a quarterly peer-reviewed journal.  Its purpose is to serve as an international forum for debate and exploration of the key strategic, scientific, and operational issues posed by biological weapons and bioterrorism.  The Journal provides multidisciplinary analyses and perspectives essential to the creation of strategies and programs that can diminish the threat of bioweapons.   The intended audiences for this Journal are those professional communities that have strategic, scientific, or operational responsibilities critical to improving biosecurity, including medicine, public health, law, national security, bioscientific research, agriculture, food safety, and drug and vaccine development.   The Editors encourage submissions to the Journal from professionals in these fields and others who have the responsibility or opportunity to improve biosecurity. Contributors are asked to follow these guidelines:   • Send an outline or letter to jfox@upmc-biosecurity.org summarizing your paper before submitting—or even writing—the paper. We can give you quick feedback on whether the idea fits the journal.   • Do not submit papers that have been published or that are currently being considered by another journal.   • Original articles, reports, and case studies should range from 3,000 to 5,000 words. Leading edge review papers of a scientific concept or technological application of relevance to biodefense or bioweapons development may be up to 5,000 words in length.   • Editorials and commentaries may be on any issues of relevance to the field but should be succinct and include appropriate documentation. Letters to the Editors intended for publication should be no more than 500 words and may be edited.   • Avoid jargon and overly technical presentations. Our readers come from a number of different fields, and your article should be understandable to well-informed, intelligent readers from various disciplines.   • In addition to presenting the methods and results of a study, you should draw implications from the results and discuss their relevance.   • All authors and co-authors, by definition, are responsible for a significant part of the manuscript. All authors should have taken part in writing the paper, reviewing it, and revising its intellectual and technical content.  Any author whose name appears on a paper assumes responsibility and accountability for the content. All authors will be required to sign a copyright release form. CONFLICT OF INTEREST Authors must disclose any potential conflict of interest, financial or otherwise, when submitting a manuscript.  Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. Submission Guidelines Manuscripts must be submitted online using the following url: http://mc.manuscriptcentral.com/healthsecurity • Submit all manuscripts double blinded and do not put your name on every page.   • All material published in the journal is copyrighted by Mary Ann Liebert, Inc., including print and electronic rights. This ensures that requests from third parties to reproduce papers are handled efficiently and consistently and will also allow the material to be as widely disseminated as possible. Forms for this purpose will be sent to authors when manuscripts have been accepted for publication. Authors may use their own material in other publications, provided that the Journal is acknowledged as the original place of publication and that the publisher is notified in advance. CONSIDERATION OF INFORMATION THAT MIGHT INCREASE THE RISKS ASSOCIATED WITH POTENTIAL BIOWEAPON ATTACKS   Health Security was created to foster discussion of biosecurity and bioterrorism issues and to promote informed biodefense decision making amongst policymakers, technical experts, and the public.  However, the editors recognize that, in the process of promoting this critical debate, some of the articles published in this journal may contain information, such as public health biodefense preparedness vulnerabilities, biotechnologies, experimental methodologies, and medical response capacities, that could arguably lower the barriers to bioweapons attacks and/or increase the potential consequences of those attacks.  There exists a recognized and important tension between academic freedom and the potential for misapplication of scientific and other knowledge.  Judgments must be made regarding the balancing of risks against the importance of an open, robust debate on these topics.   Given that essentially all biological science information is currently unclassified and available on the worldwide web and that medical and public health planning efforts are largely proceeding in the public domain, the editors believe that it will be a rare occasion that a decision not to publish potentially sensitive information will occur.  While editorial procedures are in place to ensure such actions can occur should they be necessary, the editors have a strong commitment against withholding scientific or other information unless there are clear and compelling reasons to do so.   Preparation of Manuscripts   • Type the entire manuscript, including tables and figure legends, double-spaced with 1-inch margins on all sides. Number pages consecutively.   • Title page.  The title page should have a title of about 45 characters (including spaces).  Do not include authors’ names on this page or subsequent pages. • Abstract.  The abstract should state the topic of the article and provide a summary of its main points. It should not exceed 250 words.   • Text.  Insert appropriate subheads in the text. A typical research article will have an introduction, material and methods, results, discussion, acknowledgments, and references. Policy articles, commentaries, and other types of articles should include appropriate subheads.   • Acknowledgments.  Authors should acknowledge only those people and institutions that have made substantive contributions to the study. Details of sources of funding must be given, and any potential conflicts of interest must be declared (e.g., financial, personal, political, or academic). • References.  The references should be cited in the text using the numerical order of citation method. The reference list should be at the end of the paper, double-spaced, and organized numerically by order of citation. References should be presented according to the style of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Vancouver style)  [http://www.icmje.org/], as shown below:               Journal article             Chadee DD, Kitron U. Spatial and temporal patterns of imported malaria cases and local transmission in Trinidad. Am J Trop Med Hyg 1999;61:513-7.             Book             Fish D. Population ecology of Ixodes dammin. In: Ginsberg H, ed. Ecology and Environmental Management of Lyme Disease. Rutgers, NJ: Rutgers University Press;1993:25-42.   • Tables.  Submit each table as a separate file. Use Arabic numerals to number tables. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes.   • Illustrations.  Cite figures consecutively within the manuscript.   Please follow these guidelines for submitting artwork: • Do NOT embed art files into a Word or PDF document. • Line illustrations should be submitted at 1200 dpi. • Halftones and color should be submitted at a minimum of 300 dpi. • Save as either TIFF or EPS files. • Color art must be saved as CYMK - not RGB. • Black and White art must be submitted as grayscale – not RGB. • Do NOT submit PowerPoint, PDF, Bitmap or Excel files. Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed. You will be given directions on how to correct any files which do not pass.   ADDITIONAL INFORMATION ABOUT ART FILES   Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:   • All files should be scanned at 100% size. • 300 dpi • Final color mode: cmyk • save file as: .tif or .eps   If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf   • Permissions.  Figures, tables, and text taken from other sources must be accompanied by a written statement from both author and publisher of the original material granting permission for reproduction. Include permission from authors to cite unpublished data or papers still in press.   • Reprints.  Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.   Publisher The journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215; Telephone: (914) 740–2100; fax: (914) 740–2108; e-mail: info@liebertpub.com; web site: www.liebertpub.com. Editorial Board Editor-in-Chief Thomas V. Inglesby, MD CEO and Director UPMC Center for Health Security Editor Emeritus D. A. Henderson, MD, MPH Distinguished Scholar UPMC Center for Health Security Managing Editor Jaclyn Fox UPMC Center for Health Security Pier IV Building, Suite 210 621 E. Pratt Street Baltimore, MD 21202 Tel: (443) 573-3330 Fax: (443) 573-3305 jfox@upmc-biosecurity.org Associate Editors Amesh A. Adalja, MD Associate UPMC Center for Health Security Anita Cicero, JD COO and Deputy Director UPMC Bowen Center for Health Security Crystal Franco, MPH Associate Center for Health Security Gigi Kwik Grönvall, PhD Senior Associate UPMC Center for Health Security Jennifer B. Nuzzo, DrPH Senior  Associate UPMC Center for Health Security Sanjana Ravi, MPH Analyst Center for Health Security Monica Schoch-Spana, PhD Senior Associate UPMC Center for Health Security Tara Kirk Sell, MA Associate UPMC Center for Health Security  Eric Toner, MD Senior Associate UPMC Center for Health Security Matthew Watson  Senior Analyst UPMC Center for Health Security Founding Editor Tara O’Toole, MD, MPH  Editorial Board John Bartlett, MD Chief, Division of Infectious Diseases Johns Hopkins University School of Medicine  Georges C. Benjamin, MD Executive Director American Public Health Association Ruth Berkelman, MD Director, Center for Public Health Preparedness & Research Emory University Rollins School of Public Health RADM Kenneth W. Bernard, MD U.S. Public Health Service (Ret.) Donald S. Burke, MD Dean, University of Pittsburgh Graduate School of Public Health W. Seth Carus, PhD Distinguished Research Fellow, Center for the Study of WMD, National Defense University Gail H. Cassell, PhD Vice President, TB Drug Development, Infectious Disease Research Institute Gerald Epstein, PhD Office of Policy, CTS, US Department of Homeland Security   Ruth Faden, MPH, PhD Executive Director, Phoebe R. Berman Bioethics Institute Johns Hopkins University Anthony Fauci, MD Director, National Institute of Allergy and Infectious Diseases National Institutes of Health Sheri Fink, MD The New York Times David R. Franz, DVM, PhD Colonel, USA (Ret.) Julie Gerberding, MD, MPH President, Merck Vaccines Dan Hanfling, MD Contributing Scholar UPMC Center for Health Security  Honorable Gary Hart, PhD Former Senator and Co-Chair Commission on US National Security in the 21st Century David Heymann, MD Head and Senior Fellow Chatham House Centre on Global Health Security, London, United Kingdom John L. Hick, MD Faculty Emergency Physician, Hennepin County Medical Center Associate Professor of Emergency Medicine, University of Minnesota Stephen Higgs, PhD Research Director, Biosecurity Research Institute Peine Professor of Biosecurity Kansas State University James G. Hodge, Jr., JD, LLM Director, Public Health Law and Policy Program Sandra Day O'Connor College of Law Arizona State University Noreen A. Hynes, MD, MPH, DTM&H Director, Geographic Medicine Center of the Division of Infectious Diseases Johns Hopkins School of Medicine Robert P. Kadlec, MD Former Senior Director for Bioefense Policy, Homeland Security Council Lawrence Kerr, PhD Senior Bio Advisor, Office of the Director of National Intelligence Rickard Knutsson, PhD Director, Security Department Swedish National Veterinary Institute Uppsala, Sweden Gary Kobinger, PhD Chief, Special Pathogens Program National Microbiology Laboratory, Public Health Agency of Canada Steve H. S. Kuo, MD, MPH, PhD Director-General Taiwan Centers for Disease Control Makoto Kuroda, PhD National Institute of Infectious Diseases Tokyo, Japan Col. Randall J. Larsen, USAF (Ret.) Founder & CEO Homeland Security Associates, LLC Marcelle Layton, MD Assistant Commissioner, Communicable Disease Program New York City Department of Health and Mental Hygiene Jeffrey Levi, PhD Executive Director, Trust for America’s Health Steven S. Morse, PhD Director, Center for Public Health Preparedness Columbia University Mailman School of Public Health Michael T. Osterholm, PhD, MPH Professor & Director, Center for Infectious Disease Research and Policy University of Minnesota School of Public Health Tikki Pang (Pangestu), PhD Lee Kuan Yew School of Public Policy National University of Singapore C.J. Peters, MD Director, Center for Biodefense University of Texas Medical Branch Gregory A. Poland, MD, MACP Director, Mayo Vaccine Research Group George Poste, DVM, PhD Chief Scientist, Complex Adaptive Systems Initiative Arizona State University Tia Powell, MD Director, Montefiore-Einstein Center for Bioethics Montefiore Medical Center, Albert Einstein College of Medicine David A. Relman, MD Professor of Medicine, Infectious Diseases Stanford University School of Medicine Andy Robertson, CSC, PSM, MPH Director, Disaster Management, Regulation and Planning Western Australian Department of Health Philip Russell, MD Special Advisor to the Director Department of Health and Human Services Mark M. Rweyemamu, BVSc, PhD Executive Director, Southern African Centre for Infectious Disease Surveillance; Professor, Transboundary and Emerging Infectious Diseases, Sokoine University Morogoro, Tanzania Rumiko Shimazawa, PhD Osaka University Osaka, Japan Amin Soebandrio, MD, PhD Clinical Microbiologist, Senior Health Coordinator Ministry for Research and Technology Jakarta, Indonesia   Stanley Sonoiya, MD Senior Health Coordinator, East African Community Health Department Arusha, Tanzania Sangwoo Tak, ScD, MPH Biodefense Research Institute (BDRI) Korea University Seoul, Korea Tin Yau Wong, MD, MSc, DTM&H Head, Infection Control Branch Centre for Health Protection, Hong Kong